Aug 1 |
TEVA Q2 Earnings Beat, Generic Business Drives Sales, Stock Up
|
Jul 31 |
Teva Pharmaceutical Industries Limited (TEVA) Q2 2024 Earnings Call Transcript
|
Jul 31 |
Teva Pharmaceutical Industries (TEVA) Q2 2024 Earnings Call Transcript
|
Jul 31 |
Teva Pharmaceutical Industries Limited 2024 Q2 - Results - Earnings Call Presentation
|
Jul 31 |
Teva Pharmaceutical Industries (TEVA) Reports Q2 Earnings: What Key Metrics Have to Say
|
Jul 31 |
Is Teva Pharmaceutical Industries (TEVA) Stock Undervalued Right Now?
|
Jul 31 |
Teva Pharma Flirts With Breakout As Generic Drugs Drive Beat-And-Raise
|
Jul 31 |
Teva gains after lifting outlook on YTD performance
|
Jul 31 |
Teva Pharmaceutical beats Q2 estimates, raises outlook
|
Jul 31 |
Teva Announces Strong Growth in Second Quarter Revenues mainly driven by Generics Products in All Regions and AUSTEDO®; Raises 2024 Financial Guidance
|